Investing Profile

Andrew Hack

InvestorVC

Managing Director at Bain Capital Life Sciences

baincapital.comBoston, Massachusetts
Photo of Andrew Hack, Managing Director at Bain Capital Life Sciences

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Bain Capital Life Sciences Managing Director
$100K - $5.0M
$1.5M
5
CompanyStageDateRound SizeTotal Raised
Nuvalent
Series BMay 2021$140M
$190M
Co-investors: Cameron Wheeler (Deerfield Management)
Xilio Therapeutics
Series CFeb 2021$95M
$330M
Co-investors: Mike Ross (SV Health Investors), Jayson Punwani (Abingworth), Peter Dudek (MRL Ventures Fund), Nancy Hong (RiverVest), Jack Kenney (SV Health Investors)
Atea Pharmaceuticals
Series DMay 2020$220M
$220M
Affinivax
Series BApr 2020$120M
$350M
Co-investors: Dorothy Margolskee (Foresite Capital)
JenaValve Technology
Series DFeb 2020$50M
$150M
Co-investors: Olivier Litzka (Andera Partners), Peter Barrett (Atlas Venture)